Biolase Company Profile (NASDAQ:BIOL)

About Biolase

Biolase logoBIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOL
  • CUSIP:
Key Metrics:
  • Previous Close: $1.83
  • 50 Day Moving Average: $1.65
  • 200 Day Moving Average: $1.35
  • 52-Week Range: $0.60 - $1.98
  • Trailing P/E Ratio: N/A
  • P/E Growth: -0.67
  • Market Cap: $104.86M
  • Outstanding Shares: 58,257,000
  • Beta: 1.87
Profitability:
  • Net Margins: -30.85%
  • Return on Equity: -64.30%
  • Return on Assets: -36.03%
Debt:
  • Current Ratio: 1.91%
  • Quick Ratio: 1.15%
Additional Links:
Companies Related to Biolase:

Analyst Ratings

Consensus Ratings for Biolase (NASDAQ:BIOL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biolase (NASDAQ:BIOL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Biolase (NASDAQ:BIOL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2016        
8/1/2016Q216($0.03)($0.10)$12.90 million$13.80 millionViewN/AView Earnings Details
5/9/2016Q116($0.03)($0.07)$11.90 million$11.00 millionViewN/AView Earnings Details
3/9/2016Q415($0.09)($0.02)$13.90 million$14.50 millionViewN/AView Earnings Details
11/4/2015Q315($0.08)($0.09)$1.50 million$11.20 millionViewN/AView Earnings Details
8/5/2015Q215($0.06)($0.10)$12.30 million$11.90 millionViewN/AView Earnings Details
3/4/2015Q414($0.04)($0.06)$14.90 million$13.20 millionViewN/AView Earnings Details
11/4/2014Q314($0.09)($0.08)$11.70 million$12.70 millionViewN/AView Earnings Details
8/7/2014Q214($0.08)($0.17)$12.97 million$10.20 millionViewN/AView Earnings Details
5/12/2014Q114($0.05)($0.11)$13.29 million$11.50 millionViewN/AView Earnings Details
3/5/2014Q413($0.04)($0.04)$15.67 million$15.20 millionViewN/AView Earnings Details
11/5/2013Q313($0.05)($0.10)$16.42 million$12.30 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.04)($0.06)$15.69 million$14.20 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.01)($0.06)$14.48 million$14.60 millionViewN/AView Earnings Details
3/6/2013Q4 2012$0.05$18.03 million$19.10 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biolase (NASDAQ:BIOL)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Biolase (NASDAQ:BIOL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biolase (NASDAQ:BIOL)
Insider Ownership Percentage: 7.30%
Institutional Ownership Percentage: 39.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/18/2016Jack W SchulerMajor ShareholderBuy500$0.80$400.00View SEC Filing  
2/17/2016Jack W SchulerMajor ShareholderBuy4,100$0.80$3,280.00View SEC Filing  
2/12/2016Jack W SchulerMajor ShareholderBuy19,080$0.76$14,500.80View SEC Filing  
2/10/2016Jack W SchulerMajor ShareholderBuy67,213$0.78$52,426.14View SEC Filing  
1/25/2016Jack W SchulerMajor ShareholderBuy1,400$0.80$1,120.00View SEC Filing  
1/22/2016Jack W SchulerMajor ShareholderBuy6,670$0.78$5,202.60View SEC Filing  
1/20/2016Jack W SchulerMajor ShareholderBuy24,200$0.75$18,150.00View SEC Filing  
12/28/2015Jack W SchulerMajor ShareholderBuy18,350$0.79$14,496.50View SEC Filing  
12/24/2015Jack W SchulerMajor ShareholderBuy41,900$0.76$31,844.00View SEC Filing  
12/22/2015Jack W SchulerMajor ShareholderBuy87,200$0.74$64,528.00View SEC Filing  
12/21/2015Jack W SchulerMajor ShareholderBuy127,892$0.73$93,361.16View SEC Filing  
12/17/2015Jack W SchulerMajor ShareholderBuy34,158$0.70$23,910.60View SEC Filing  
11/11/2015Larry N FeinbergMajor ShareholderBuy54,800$0.79$43,292.00View SEC Filing  
11/10/2015Paul N ClarkDirectorBuy134,579$0.75$100,934.25View SEC Filing  
9/24/2015David C DreyerCFOBuy5,000$1.20$6,000.00View SEC Filing  
9/22/2015David C DreyerCFOBuy5,000$1.37$6,850.00View SEC Filing  
9/17/2015David C DreyerCFOBuy10,000$1.45$14,500.00View SEC Filing  
11/3/2014Jeffrey M NugentCEOBuy40,465$2.39$96,711.35View SEC Filing  
11/3/2014Jonathan T Md LordDirectorBuy101,163$2.39$241,779.57View SEC Filing  
11/3/2014Larry N FeinbergMajor ShareholderBuy2,067,979$2.39$4,942,469.81View SEC Filing  
7/22/2014Alexander K ArrowCOOBuy7,812$1.92$14,999.04View SEC Filing  
7/22/2014Frederick D FurryCFOBuy13,020$1.92$24,998.40View SEC Filing  
7/22/2014Jeffrey M NugentCEOBuy52,083$1.92$99,999.36View SEC Filing  
7/22/2014Paul N ClarkDirectorBuy520,833$1.92$999,999.36View SEC Filing  
7/18/2014Larry N FeinbergMajor ShareholderBuy2,270,836$1.92$4,360,005.12View SEC Filing  
2/12/2014Larry N FeinbergMajor ShareholderBuy2,035,033$2.57$5,230,034.81View SEC Filing  
1/31/2014Larry Feinbergmajor shareholderBuy30,798$2.45$75,455.10View SEC Filing  
12/19/2013Larry Feinbergmajor shareholderBuy340,000$1.80$612,000.00View SEC Filing  
12/17/2013Larry Feinbergmajor shareholderBuy150,400$1.87$281,248.00View SEC Filing  
8/23/2012Frederick D FurryCFOBuy5,075$1.64$8,323.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biolase (NASDAQ:BIOL)
DateHeadline
News IconBiolase, Inc. (BIOL) Updated Broker Ratings - NewsDen (NASDAQ:BIOL)
newsden.net - September 28 at 3:38 PM
News IconInterested Penny Stock Investors Keen on Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 28 at 3:38 PM
News IconArens Appointed Biolase EMEA VP - Photonics.com (NASDAQ:BIOL)
www.photonics.com - September 28 at 3:38 PM
News IconGlobal Dental Surgical Equipment Market 2016: Biolase Inc, Danaher Corp, Midmark Corp, PLANMECA Oy, Sirona ... - Digital Journal (NASDAQ:BIOL)
www.digitaljournal.com - September 27 at 3:51 PM
News IconPenny Stock Investors are Growing Curious About BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 27 at 3:51 PM
News IconUnder the Microscope: Zeroing in on Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 27 at 8:26 AM
newsmaker.com.au logoGlobal Dental Diagnostic Equipment Market 2016: Biolase Inc, Danaher Corp, Midmark Corp, PLANMECA Oy, Sirona ... - NewsMaker (press release) (NASDAQ:BIOL)
www.newsmaker.com.au - September 26 at 3:58 PM
capitalcube.com logoETF’s with exposure to BIOLASE, Inc. : September 26, 2016 (NASDAQ:BIOL)
www.capitalcube.com - September 26 at 3:58 PM
News IconKeen Investors Find News on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 24 at 8:05 AM
finance.yahoo.com logoBIOLASE Names Holger Arens Vice President, Managing Director EMEA - Yahoo Finance (NASDAQ:BIOL)
finance.yahoo.com - September 23 at 3:18 PM
News IconUnder the Microscope, Zeroing in at BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 22 at 4:00 PM
News IconPenny Stock Investors Keen on Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 22 at 8:04 AM
businesswire.com logoBIOLASE Names Holger Arens Vice President, Managing Director EMEA - Business Wire (press release) (NASDAQ:BIOL)
www.businesswire.com - September 22 at 8:04 AM
publicnow.com logoBIOLASE Names Holger Arens Vice President, Managing Director EMEA (NASDAQ:BIOL)
www.publicnow.com - September 22 at 8:04 AM
News IconPenny Stock Investors Take an Interest in BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 21 at 8:23 AM
News IconUnder the Microscope: Getting a Closer Look at Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 20 at 9:07 AM
News Iconprateek cv (NASDAQ:BIOL)
www.slideshare.net - September 17 at 8:38 AM
News IconBiolase Technology Incorporated (NASDAQ:BIOL) Shorted Shares Increased 1.16% After Market Selling - Post News (NASDAQ:BIOL)
www.kentuckypostnews.com - September 16 at 3:47 PM
News IconKeen Investors Seek Information on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 16 at 3:47 PM
kcregister.com logoTop Wall Street Stories: BIOLASE, Inc. (NASDAQ:BIOL), Verizon Communications Inc. (NYSE:VZ), Elmira Savings Bank ... - KC Register (NASDAQ:BIOL)
www.kcregister.com - September 15 at 12:47 PM
News IconStock Update, a Closer Look at BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 15 at 12:47 PM
News IconPenny Stock Investors Highly Curious in Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 14 at 3:52 PM
News IconKeen Investors Narrowing Their Focus on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - September 14 at 3:52 PM
businesswire.com logoBIOLASE Enters into Clinical Research Agreement with McGuire Institute for Landmark Laser Perio Research Project - Business Wire (press release) (NASDAQ:BIOL)
www.businesswire.com - September 14 at 3:52 PM
streetinsider.com logoBiolase (BIOL), The McGuire Institute Enter Agreement for Landmark Laser Perio Research Project (NASDAQ:BIOL)
www.streetinsider.com - September 13 at 8:43 AM
finance.yahoo.com logo5:16 pm Biolase enters into clinical research agreement with McGuire Institute for laser perio research project (NASDAQ:BIOL)
finance.yahoo.com - September 13 at 8:43 AM
publicnow.com logoBIOLASE Enters into Clinical Research Agreement with McGuire Institute for Landmark Laser Perio Research Project (NASDAQ:BIOL)
www.publicnow.com - September 13 at 8:43 AM
News IconLearn details of the world dental equipment market - opportunities and forecasts, 2014 - 2022 (NASDAQ:BIOL)
www.whatech.com - September 7 at 8:57 PM
capitalcube.com logoETF’s with exposure to BIOLASE, Inc. : August 29, 2016 (NASDAQ:BIOL)
www.capitalcube.com - August 29 at 4:27 PM
News IconNow Available – Worldwide Directed Energy-Based Surgical Systems Market Report 2015-2025 (NASDAQ:BIOL)
www.medgadget.com - August 26 at 11:55 AM
News IconDirected Energy-Based Surgical Systems Market Segments and Key Trends 2015-2025 (NASDAQ:BIOL)
reports.pr-inside.com - August 17 at 9:18 PM
sbwire.com logoDental Equipment Market Sale Value US$5.5 Bn at 2011,Estimated to Reach US$7.6 Bn by 2018 - Research Proved (NASDAQ:BIOL)
www.sbwire.com - August 16 at 3:57 PM
prnewswire.com logoDental Equipment Market by Product & End User - Global Forecast to 2021 (NASDAQ:BIOL)
www.prnewswire.com - August 16 at 3:57 PM
News IconStock Update on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL)
www.duncanindependent.com - August 11 at 3:53 PM
4-traders.com logoPalamina Announces Closing of Oversubscribed $1.2M Private Placement (NASDAQ:BIOL)
www.4-traders.com - August 8 at 9:16 PM
biz.yahoo.com logoBIOLASE, INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rights of Security (NASDAQ:BIOL)
biz.yahoo.com - August 8 at 9:16 PM
finance.yahoo.com logoBIOLASE, INC Financials (NASDAQ:BIOL)
finance.yahoo.com - August 6 at 4:16 PM
streetinsider.com logoForm 4 BIOLASE, INC For: Aug 01 Filed by: CLARK PAUL N - StreetInsider.com (NASDAQ:BIOL)
www.streetinsider.com - August 4 at 9:36 PM
biz.yahoo.com logoBIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat (NASDAQ:BIOL)
biz.yahoo.com - August 2 at 3:53 PM
einnews.com logoDental Surgical Instrument Research Industry Trends, Growth – Forecast to 2027 (NASDAQ:BIOL)
www.einnews.com - August 2 at 8:38 AM
biz.yahoo.com logoBIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:BIOL)
biz.yahoo.com - August 1 at 3:49 PM
biz.yahoo.com logoQ2 2016 BIOLASE Inc Earnings Release - After Market Close (NASDAQ:BIOL)
biz.yahoo.com - August 1 at 7:07 AM
publicnow.com logoBIOLASE Reports 2016 Second Quarter and Six-Month Results (NASDAQ:BIOL)
www.publicnow.com - August 1 at 6:41 AM
publicnow.com logoBIOLASE to Raise $10 Million from Institutional and Individual Investors in Convertible Preferred Private Placement (NASDAQ:BIOL)
www.publicnow.com - August 1 at 6:21 AM
sg.finance.yahoo.com logoBiolase reports 2Q loss (NASDAQ:BIOL)
sg.finance.yahoo.com - August 1 at 6:20 AM
News IconNew report: Dental equipment market is projected to reach 7.52 billion USD by 2021 (NASDAQ:BIOL)
www.whatech.com - July 25 at 4:21 PM
4-traders.com logoBIOLASE : reg; to Host 2016 Second Quarter Financial Results Conference Call on August 1 (NASDAQ:BIOL)
www.4-traders.com - July 25 at 8:38 AM
publicnow.com logoBIOLASE® to Host 2016 Second Quarter Financial Results Conference Call on August 1 (NASDAQ:BIOL)
www.publicnow.com - July 25 at 6:28 AM
News IconGlaukos CFO to Retire in 2017 (NASDAQ:BIOL)
www.ocbj.com - July 24 at 8:33 AM
News IconStock Up Nicely This Week: BIOLASE, Inc. (NASDAQ:BIOL) - TGP (NASDAQ:BIOL)
telanaganapress.com - July 23 at 3:47 PM

Social

Biolase (NASDAQ:BIOL) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff